Correction: Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study
Pranjal Vats, Rajan Rolta, Deeksha Salaria, Ishika Sharma, Anita Verma, Olatomide A. Fadare, Mansi Verma · 2025
Read Correction: Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study by Pranjal Vats, Rajan Rolta, Deeksha Salaria, Ishika Sharma, Anita Verma, Olatomide A. Fadare, Mansi Verma (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12727721.txt.
Description
subheading ‘Virtual screening and molecular Docking’ has been corrected to “Molecular Docking”. Under the subheading ‘In silico toxicity prediction of phytocompounds and drugs’, “The analysis utilized several tools, including SwissADME (http://www.swissadme.ch), MolInspirationCheminformatics (https://www.molinspiration.com), and PROTOX 3.0 (https://tox-new.charite.de/protox_II/).” now reads: “The analysis utilized several tools, including SwissADME (http://www.swissadme.ch), MolInspirationCheminformatics (https://www.molinspiration.com), and ProTox 3.0 (https://tox.charite.de/protox3/).
Catalog record
| CREATOR | Pranjal Vats, Rajan Rolta, Deeksha Salaria, Ishika Sharma, Anita Verma, Olatomide A. Fadare, Mansi Verma |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Correction: Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study Authors: Pranjal Vats, Rajan Rolta, Deeksha Salaria, Ishika Sharma, Anita Verma, Olatomide A. Fadare, Mansi Verma Published: 2025 Correction to: Scientific Reports 10.1038/s41598-025-06974-y, published online 30 July 2025 In the original version of this Article, the abbreviation “MMPBSA” was incorrectly given as “MMBPSA”. In addition, in the Methods section, the subheading ‘Virtual screening and molecular Docking’ has been corrected to “Molecular Docking”. Under the subheading ‘In silico toxicity prediction of phytocompounds and drugs’, “The analysis utilized several tools, including SwissADME (http://www.swissadme.ch), MolInspirationCheminformatics (https://www.molinspiration.com), and PROTOX 3.0 (https://tox-new.charite.de/protox_II/).” now reads: “The analysis utilized several tools, including SwissADME (http://www.swissadme.ch), MolInspirationCheminformatics (https://www.molinspiration.com), and ProTox 3.0 (https://tox.charite.de/protox3/).” Under the subheading ‘Molecular dynamics (MD) simulation’, “For long-range electrostatics, Particle-mesh Ewald (PME) algorithm was used. The snapshots of poses from the last frame of the trajectory are presented in Fig. 3. After successful completion of molecular dynamic simulation for 100 ns, Root mean square deviation (RMSD) of backbone residues, number of Hydrogen bonds, Root mean square fluctuations (RMSF), Radius of gyration (RG) and solvent accessible surface area (SASA)were calculated from the trajectory files from each complex.” now reads: “For long-range electrostatics, Particle-mesh Ewald (PME) algorithm was used. After successful completion of molecular dynamic simulation for 100 ns, Root mean square deviation (RMSD) of backbone residues, number of Hydrogen bonds, Root mean square fluctuations (RMSF), Radius of gyration (RG) and solvent accessible surface area (SASA)were calculated from the trajectory files from each complex.” In the Results section, “Comprehensive data on the binding affinities of each compound with all serotypes can be found in Table 2 for detailed reference (Table 3).” now reads: “Comprehensive data on the binding affinities of each compound with all serotypes can be found in Table 2.” Furthermore, the caption of Table 6 was incomplete. “Energy decomposition for free energy of binding (FEB) estimated for target proteins bound to respective inhibitors and lupiwighteone.” now reads: “Energy decomposition for free energy of binding (FEB) estimated for target proteins bound to respective inhibitors and lupiwighteone. VDWAALS = van der Waals energy, EEL = electrostatic energy, EPB = polar solvation energy, ENPOLAR = non-polar solvation energy, GGAS = gas-phase energy (VDWAALS + EEL), GSOLV = solvation free energy (EPB + ENPOLAR); all values in kcal/mol.”